We found that expression of two genes in this pathway, C4A and C4B, were significantly up-regulated in AD cases compared to controls regardless of APOE genotype, but the difference was larger and more significant among ε2/ε3 individuals despite the smaller sample size compared to other APOE genotypes. The gene discussed is C4B; the disease is Alzheimer disease.